Starry Sea Acquisition Corp

Aktienanalyse zu Starry Sea Acquisition Corp (SSEA)

$10.300

0.000 (0.00%)Zum Schluss

Loading chart…
High
10.300
Open
10.300
VWAP
Vol
0.00
Mkt Cap
Low
10.300
Amount
0.00
EV/EBITDA, TTM
0.00

Starry Sea Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.

AI analysis of Starry Sea Acquisition Corp (SSEA)

hold

Starry Sea Acquisition Corp is currently not a strong buy due to its low RSI of 37.437, indicating it is nearing oversold territory, but it has not yet reached a buying signal. Additionally, the forward P/E ratio is 0, suggesting uncertainty about future earnings. The recent merger with SuperiorMed could provide potential upside, but the stock's performance has been stagnant with a 5-day change of -0.10%.

Bewertungskennzahlen

The current forward P/E ratio for Starry Sea Acquisition Corp (SSEA) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
Überbewertet
0.00
Unterbewertet
0.00

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Überbewertet
0.00
Unterbewertet
0.00

Forward P/S

Fair
5Y Average P/S
0.14
Current P/S
0.00
Überbewertet
1.33
Unterbewertet
-1.04

SSEA FAQ — answered by Alphio AI

Starry Sea Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. It operates in the Financials sector.

Starry Sea Acquisition Corp is currently not a strong buy due to its low RSI of 37.437, indicating it is nearing oversold territory, but it has not yet reached a buying signal. Additionally, the forward P/E ratio is 0, suggesting uncertainty about future earnings. The recent merger with SuperiorMed could provide potential upside, but the stock's performance has been stagnant with a 5-day change of -0.10%.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten